Research summary

A Review on Recent Advances of Cerebral Palsy

Authors of report
Sudip Paul, Anjuman Nahar, Mrinalini Bhagawati, Ajaya Jang Kunwar
Date of report
Medical conditions
Cerebral Palsy

Major Points and Findings:

  1. Objective: The narrative review aims to summarize the latest advances in cerebral palsy (CP) and identify areas where more research is required.
  2. Prevalence and Risk Factors:
    • The prevalence of CP is 2-3 per 1000 live births.
    • Major factors correlated with CP are gestational age and birth weight.
    • Risk factors for CP span across different stages: preconception, prenatal, perinatal, and postnatal.
    • The highest contributing risk factor is prematurity and being underweight.
  3. Classification:
    • CP is classified into three main forms: spastic (80%), dyskinetic (15%), and ataxic (5%).
  4. Diagnosis:
    • Diagnosis of CP is based on clinical investigation and neurological examinations.
    • Tools used include magnetic resonance imaging (MRI), biomarkers, and cranial ultrasound.
  5. Treatment:
    • Various treatment procedures for CP include medical and surgical interventions, physiotherapy, occupational therapy, umbilical milking, nanomedicine, and stem cell therapy.
    • Technological advancements in the treatment and diagnosis of CP were also discussed in the review.
  6. Conclusion:
    • CP is the most common neuromotor disability with a prevalence rate mentioned above.
    • Several prevention and diagnostic techniques, such as MRI and ultrasound, are currently in use.
    • Treatments like cord blood treatment, nanomedicine, and stem cell therapy are areas that need further investigation for future clinical application.
    • The review also emphasizes the need for future studies in the context of technological advancements among children with cerebral palsy.

This is a summary of independent research published elsewhere. It is not a report of Beike treatment outcomes.

Free consultation

Speak with a medical advisor

No obligation. We’ll review your situation and respond within 48 hours.

  • Response within 48 hours from a medical advisor.
  • Confidential — your information stays with our medical team.
  • No cost, no obligation. We review your case and respond.

Reviewed by the Beike medical advisory team — answering patient inquiries since 2005.

If your diagnosis is not listed, please select 'other'.

Internationally accredited

Held to global laboratory and biologics standards.